These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

189 related items for PubMed ID: 20203148

  • 1. Lesion enhancement diminishes with time in primary progressive multiple sclerosis.
    Khaleeli Z, Ciccarelli O, Mizskiel K, Altmann D, Miller DH, Thompson AJ.
    Mult Scler; 2010 Mar; 16(3):317-24. PubMed ID: 20203148
    [Abstract] [Full Text] [Related]

  • 2. Responsiveness and predictive value of EDSS and MSFC in primary progressive MS.
    Kragt JJ, Thompson AJ, Montalban X, Tintoré M, Río J, Polman CH, Uitdehaag BM.
    Neurology; 2008 Mar 25; 70(13 Pt 2):1084-91. PubMed ID: 18184917
    [Abstract] [Full Text] [Related]

  • 3. Evolution of T1 black holes in patients with multiple sclerosis imaged monthly for 4 years.
    Bagnato F, Jeffries N, Richert ND, Stone RD, Ohayon JM, McFarland HF, Frank JA.
    Brain; 2003 Aug 25; 126(Pt 8):1782-9. PubMed ID: 12821527
    [Abstract] [Full Text] [Related]

  • 4. Cortical lesions in primary progressive multiple sclerosis: a 2-year longitudinal MR study.
    Calabrese M, Rocca MA, Atzori M, Mattisi I, Bernardi V, Favaretto A, Barachino L, Romualdi C, Rinaldi L, Perini P, Gallo P, Filippi M.
    Neurology; 2009 Apr 14; 72(15):1330-6. PubMed ID: 19365054
    [Abstract] [Full Text] [Related]

  • 5. Grey matter damage predicts the evolution of primary progressive multiple sclerosis at 5 years.
    Rovaris M, Judica E, Gallo A, Benedetti B, Sormani MP, Caputo D, Ghezzi A, Montanari E, Bertolotto A, Mancardi G, Bergamaschi R, Martinelli V, Comi G, Filippi M.
    Brain; 2006 Oct 14; 129(Pt 10):2628-34. PubMed ID: 16921179
    [Abstract] [Full Text] [Related]

  • 6. Voxel-based assessment of differences in damage and distribution of white matter lesions between patients with primary progressive and relapsing-remitting multiple sclerosis.
    Di Perri C, Battaglini M, Stromillo ML, Bartolozzi ML, Guidi L, Federico A, De Stefano N.
    Arch Neurol; 2008 Feb 14; 65(2):236-43. PubMed ID: 18268194
    [Abstract] [Full Text] [Related]

  • 7. ADC measurements in various patterns of multiple sclerosis lesions.
    Phuttharak W, Galassi W, Laopaiboon V, Laopaiboon M, Hesselink JR.
    J Med Assoc Thai; 2006 Feb 14; 89(2):196-204. PubMed ID: 16579006
    [Abstract] [Full Text] [Related]

  • 8. Increased plasma 8,12-iso-iPF2alpha- VI levels in relapsing multiple sclerosis patients are not predictive of disease progression.
    Teunissen CE, Sombekke M, van Winsen L, Killestein J, Barkhof F, Polman CH, Dijkstra CD, Blankenstein MA, Pratico D.
    Mult Scler; 2012 Aug 14; 18(8):1092-8. PubMed ID: 22695538
    [Abstract] [Full Text] [Related]

  • 9. Two-year study of cervical cord volume and myelin water in primary progressive multiple sclerosis.
    Laule C, Vavasour IM, Zhao Y, Traboulsee AL, Oger J, Vavasour JD, Mackay AL, Li DK.
    Mult Scler; 2010 Jun 14; 16(6):670-7. PubMed ID: 20558500
    [Abstract] [Full Text] [Related]

  • 10. Brain atrophy evolution and lesion load accrual in multiple sclerosis: a 2-year follow-up study.
    Tedeschi G, Dinacci D, Comerci M, Lavorgna L, Savettieri G, Quattrone A, Livrea P, Patti F, Morra VB, Servillo G, Orefice G, Paciello M, Prinster A, Coniglio G, Bonavita S, Di Costanzo A, Bellacosa A, Valentino P, Quarantelli M, Brunetti A, Salemi G, D'Amelio M, Simone I, Salvatore M, Bonavita V, Alfano B.
    Mult Scler; 2009 Feb 14; 15(2):204-11. PubMed ID: 18987104
    [Abstract] [Full Text] [Related]

  • 11. The natural history of primary progressive multiple sclerosis.
    Koch M, Kingwell E, Rieckmann P, Tremlett H.
    Neurology; 2009 Dec 08; 73(23):1996-2002. PubMed ID: 19996074
    [Abstract] [Full Text] [Related]

  • 12. Primary progressive multiple sclerosis diagnostic criteria: a reappraisal.
    Montalban X, Sastre-Garriga J, Filippi M, Khaleeli Z, Téllez N, Vellinga MM, Tur C, Brochet B, Barkhof F, Rovaris M, Miller DH, Polman CH, Rovira A, Thompson AJ.
    Mult Scler; 2009 Dec 08; 15(12):1459-65. PubMed ID: 19995843
    [Abstract] [Full Text] [Related]

  • 13. In vivo assessment of cervical cord damage in MS patients: a longitudinal diffusion tensor MRI study.
    Agosta F, Absinta M, Sormani MP, Ghezzi A, Bertolotto A, Montanari E, Comi G, Filippi M.
    Brain; 2007 Aug 08; 130(Pt 8):2211-9. PubMed ID: 17535835
    [Abstract] [Full Text] [Related]

  • 14. Relationship between MRI lesion activity and response to IFN-beta in relapsing-remitting multiple sclerosis patients.
    Río J, Rovira A, Tintoré M, Huerga E, Nos C, Tellez N, Tur C, Comabella M, Montalban X.
    Mult Scler; 2008 May 08; 14(4):479-84. PubMed ID: 18562504
    [Abstract] [Full Text] [Related]

  • 15. A randomized crossover study of bee sting therapy for multiple sclerosis.
    Wesselius T, Heersema DJ, Mostert JP, Heerings M, Admiraal-Behloul F, Talebian A, van Buchem MA, De Keyser J.
    Neurology; 2005 Dec 13; 65(11):1764-8. PubMed ID: 16221950
    [Abstract] [Full Text] [Related]

  • 16. Conventional and magnetization transfer MRI predictors of clinical multiple sclerosis evolution: a medium-term follow-up study.
    Rovaris M, Agosta F, Sormani MP, Inglese M, Martinelli V, Comi G, Filippi M.
    Brain; 2003 Oct 13; 126(Pt 10):2323-32. PubMed ID: 12937086
    [Abstract] [Full Text] [Related]

  • 17. Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis.
    Minneboo A, Barkhof F, Polman CH, Uitdehaag BM, Knol DL, Castelijns JA.
    Arch Neurol; 2004 Feb 13; 61(2):217-21. PubMed ID: 14967769
    [Abstract] [Full Text] [Related]

  • 18. The natural history of primary progressive MS in British Columbia, Canada.
    Tremlett H, Paty D, Devonshire V.
    Neurology; 2005 Dec 27; 65(12):1919-23. PubMed ID: 16380613
    [Abstract] [Full Text] [Related]

  • 19. The relationship between inflammation and atrophy in clinically isolated syndromes suggestive of multiple sclerosis: a monthly MRI study after triple-dose gadolinium-DTPA.
    Paolillo A, Piattella MC, Pantano P, Di Legge S, Caramia F, Russo P, Lenzi GL, Pozzilli C.
    J Neurol; 2004 Apr 27; 251(4):432-9. PubMed ID: 15083288
    [Abstract] [Full Text] [Related]

  • 20. Correlations between monthly enhanced MRI lesion rate and changes in T2 lesion volume in multiple sclerosis.
    Molyneux PD, Filippi M, Barkhof F, Gasperini C, Yousry TA, Truyen L, Lai HM, Rocca MA, Moseley IF, Miller DH.
    Ann Neurol; 1998 Mar 27; 43(3):332-9. PubMed ID: 9506550
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.